News 
ATLANTA, Georgia (CNN) -- For the first time in the United States, stem cells have been directly injected into the spinal cord of a patient, researchers announced Thursday. Doctors injected stem cells from 8-week-old fetal tissue into the spine of a man in his early 60s who has advanced ALS, or amyotrophic lateral sclerosis. It was part of a clinical trial designed to determine whether it is safe to inject stem cells into the spinal cord and whether the cells themselves are safe. (More...)  ROCKVILLE, Maryland, December 18, 2009 –Neuralstem, Inc. (NYSE Amex: CUR) today announced that its Phase I trial to treat Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig’s disease) with its spinal cord stem cells has been approved by the Institutional Review Board (IRB) at Emory University in Atlanta, GA. The trial, which was approved by the FDA in September, will take place at the Emory ALS Center, under the direction of Dr. Jonathan Glass M.D., Director of the Emory ALS Center, who will serve as the site Principal Investigator (PI). (More...)
 November 27, 2009 - Atlanta Business Chronicle - by Urvaksh Karkaria Staff Writer - Emory University will be the site of the first U.S. clinical trail that focuses on using stem cells to slow the progression of adults with Lou Gehrig’s disease.
more...  Neuralstem gets FDA OK to test stem cell drug in humans. Reuters reports: " U.S. health regulators allowed the stem-cell research company to start an early-stage human trial of its spinal cord stem cells in Lou Gehrig's disease, a fatal neuromuscular condition." more...
View our safe harbour statement | 
